Auditor Issues Adverse Opinion on Internal Controls Amid Ongoing SEC Probe and New Lawsuits
Summary
Kyndryl's auditor issued an adverse opinion on internal controls, compounding risks from an ongoing SEC investigation and new class-action lawsuits, despite operational improvements and share repurchases.
Key Events
-
Adverse Opinion on Internal Controls
PricewaterhouseCoopers LLP issued an adverse opinion on the effectiveness of the company's internal control over financial reporting as of March 31, 2026, citing material weaknesses related to tone at the top, communication in disclosure processes, and internal complaint investigation.
-
Ongoing SEC Investigation and New Lawsuits
The company continues to cooperate with an SEC investigation into cash management practices and related disclosures. Additionally, two new putative class-action lawsuits were filed in February and March 2026, alleging false and misleading statements.
-
Significant Decline in Signings
Total signings decreased by 26% to $13.5 billion for the year ended March 31, 2026, compared to $18.2 billion in the prior year, impacted by lengthening sales cycles.
-
Failed Strategic Acquisition
The planned acquisition of Solvinity Group B.V. for approximately €100 million was prohibited by Dutch regulators on May 25, 2026, representing a setback for strategic expansion.
Analysis
Kyndryl Holdings, Inc. received an adverse opinion from its auditor, PricewaterhouseCoopers LLP, regarding the effectiveness of its internal control over financial reporting as of March 31, 2026. This is a critical governance failure, confirming previously disclosed material weaknesses and indicating a significant risk to the reliability of financial reporting. The company also faces an ongoing SEC investigation into cash management practices and new class-action lawsuits alleging misleading statements, further highlighting severe legal and regulatory risks. While the company announced a new workforce rebalancing plan expected to yield substantial future savings and continued its share repurchase program, these positive operational and capital allocation efforts are heavily overshadowed by the fundamental issues with financial controls, legal scrutiny, and a notable 26% decline in new business signings.
At the time of this filing, KD was trading at $11.78 on NYSE in the Technology sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $10.10 to $44.20. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.